STAAR Surgical Co (STAA) stock

STAANasdaqOphthalmic GoodsFiscal year ends January 2

Financials through Q3 FY2026, quarter ended Oct 2, 2026Last filing: 10-Q on Nov 4, 2026Score 8/30

$26.78+0.09 (+0.34%)

Close on Nov 12, 2026Market cap $1.34BP/E –Yield –

STAAR Surgical ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

STAAR Surgical has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in STAAR Surgical's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-2 reverse split on May 18, 1992
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing